World Psoriasis Day: Advancing early detection of psoriatic arthritis through iPROLEPSIS

World Psoriasis Day: Advancing Early Detection of Psoriatic Arthritis

Every year on 29 October, World Psoriasis Day raises awareness of the 125 million people worldwide living with psoriatic arthritis (PsA), a chronic condition affecting skin, joints, and quality of life.

This year's observance highlights European research, powered by innovation and collaboration, paving the way for earlier diagnosis and personalised treatment of PsA through projects like iPROLEPSIS.

The iPROLEPSIS Project

Coordinated by Professor Leontios Hadjileontiadis, iPROLEPSIS is developing advanced tools to detect psoriatic arthritis early, before irreversible joint damage occurs, under the Horizon Europe programme.

Psoriatic arthritis often develops in people who already have psoriasis, but its early symptoms can be subtle or mistaken for other conditions.

Delayed diagnosis can lead to permanent joint deformities and reduced mobility, which iPROLEPSIS aims to change by creating predictive tools for early detection.

Author's Summary

iPROLEPSIS project advances early PsA detection.

Open Access Government — 2025-10-29